Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Initially, or after preoperative chemotherapy, patients with a kidney tumor are examined on 3T MR scanner or 1.5T MR scanner. A standard MRI study of the abdomen with contrast enhancement is performed. DWI (diffusion weighted) images are included in the standard investigation package and consist of diffusion maps. Then, using Philips workstation (ISP 9.0, Philips, Netherlands), DWI mapping and ADC values collection (mm2/s) are performed. The placement of region of interest (ROI) is selected in the kidney mass in a solid and cystic area with a size up to 100 mm2.
After the preoperative abdomen MRI, a surgical treatment is performed. Histological material is directed to the pathologist, who carried out the histological staging by the malignancy degree (low, intermediate, high). The data is entered into the database and the relationship between ADC values and histological degrees of malignancy of nephroblastoma is investigated
Initially, or after preoperative chemotherapy, patients with a kidney tumor are examined on 3T MR scanner or 1.5T MR scanner, using 8-channel body coil. A standard MRI study of the abdomen with contrast enhancement is performed. DWI (diffusion weighted) images are included in the standard investigation package and consist of diffusion maps (DWI 3b) with 3 b-factors (50; 600; 800 or others, optional). Then, using Philips workstation (ISP 9.0, Philips, Netherlands), DWI mapping and ADC values collection (mm2/s) are performed. The placement of region of interest (ROI) is selected in the kidney mass in a solid and cystic area with a size up to 100 mm2. The values are entered in the table due to the stage of the chemotherapy.
After the preoperative abdomen MRI, a surgical treatment is performed. Histological material is directed to the pathologist, who carried out the histological staging by the malignancy degree (low, intermediate, high). The data is entered into the database and the relationship between ADC values and histological degrees of malignancy of nephroblastoma is investigated.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MRI DWI sequence (ADC values) | Diagnostic Test | Initially and after pre-operative chemotherapy To evaluate the differences in ADC values according to the malignancy degree of nephroblastoma in children |
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate the differences in ADC values according to the malignancy degree of nephroblastoma in children | Point 1. 15 ± 3 days Before the start of therapy - the starting point. | |
| To evaluate the differences in ADC values according to the malignancy degree of nephroblastoma in children | Point 2. after pre-operative chemotherapy up to 1 week |
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate the reproducibility and compatibility of the ADC values measurement; | Point 1. 15 ± 3 days Before the start of therapy - the starting point. | |
| To evaluate the reproducibility and compatibility of the ADC values measurement; | Point 2. after pre-operative chemotherapy up to 1 week |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Evelina f Nazarova | Contact | +79161133945 | evelina.nazarova@fccho-moscow.ru |
| Name | Affiliation | Role |
|---|---|---|
| Galina f Tereshchenko, PhD | Chief radiology department at Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dmitry Rogachev National Medical Research Centre of Pediatric Hematology, Oncology and Immunology | Recruiting | Moscow | Russia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009396 | Wilms Tumor |
| D009369 | Neoplasms |
| ID | Term |
|---|---|
| D018193 | Neoplasms, Complex and Mixed |
| D009370 | Neoplasms by Histologic Type |
| D007680 | Kidney Neoplasms |
| D014571 | Urologic Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| To assess the sensitivity and specificity of the MRI DWI sequence (ADC values) in the diagnosis of the malignancy degrees of nephroblastomas in children; | Point 1. 15 ± 3 days Before the start of therapy - the starting point. |
| To assess the sensitivity and specificity of the MRI DWI sequence (ADC values) in the diagnosis of the malignancy degrees of nephroblastomas in children; | Point 2. after pre-operative chemotherapy up to 1 week |
| To estimate the differences in ADC values within the intermediate degree of nephroblastoma malignancy in children | Point 1. 15 ± 3 days Before the start of therapy - the starting point. |
| To estimate the differences in ADC values within the intermediate degree of nephroblastoma malignancy in children | Point 2. after pre-operative chemotherapy up to 1 week |
| To assess the ADC values change in depending according to the provided chemotherapy. | Point 1. 15 ± 3 days Before the start of therapy - the starting point. |
| To assess the ADC values change in depending according to the provided chemotherapy. | Point 2. after pre-operative chemotherapy up to 1 week |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009386 | Neoplastic Syndromes, Hereditary |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052801 | Male Urogenital Diseases |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |